Since TIMP3 has broad-spectral inhibition activity on both MMPs and ADAMs (Brew and Nagase, 2010; Murphy, 2011), TIMP3 target protease activities might be differentially involved in tumor growth and metastatic conversion. The gene discussed is TIMP3; the disease is neoplasm.